⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BMY News
Bristol-Myers Squibb Co.
Dark Blue Therapeutics acquired by Amgen for up to $840 million
prnewswire.com
AMGN
BMY
Cell and Gene Therapy Market Projected to Reach US$ 183.1 Billion by 2035, Supported by Expanding Global Clinical Trial Activity Says Astute Analytica
globenewswire.com
NVS
ABBV
BNTX
LLY
BMY
GILD
Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report USA - English India - English
prnewswire.com
CLVT
LLY
GSK
JNJ
SNY
CELC
CRBP
BMY
Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and Strategic Collaborations - ResearchAndMarkets.com
businesswire.com
MRK
BMY
AZN
JNJ
NVS
Bristol Myers Squibb to Present at J.P. Morgan’s 44 th Annual Healthcare Conference
businesswire.com
BMY
Bipolar Disorder Market Opportunity Assessment and Forecast Report 2024-2034: Addressing Treatment Gaps in Bipolar Depression, Early Diagnosis, Patient Adherence, and Clinical Trial Effectiveness - ResearchAndMarkets.com
businesswire.com
BMY
VNDA
XENE
Football Legend Tom Brady Joins Visionary Entrepreneur and Renowned Speaker Sean Callagy for Exclusive Interview on "Unblinded" Podcast
accessnewswire.com
TMUS
DIS
BMY
CRM
MA
The Skin of Color Society (SOCS) Reports an Impactful Year of Progress, Expansion, and Innovation Toward Advancing Knowledge and Excellence in Patient Care
prnewswire.com
JNJ
LLY
SNY
REGN
ABBV
AERO
BIIB
GALT
TAK
ELMD
PFE
SUN
INCY
BMY
ARQT
UCB
Debbie's Dream Foundation: Curing Stomach Cancer Thanks Its 2025 Industry Partners for Advancing Critical Programs and Patient Support
prnewswire.com
AMGN
BMY
ARCX
AZN
GILD
JAZZ
LLY
MRK
ASTL
THTX
Cell and Gene Therapy Market to Exceed US$105B by 2033, Driving Strategic Value Across Healthcare Portfolios | According to DataM Intelligence
prnewswire.com
EDIT
NTLA
RPTX
NVS
GILD
BMY
VRTX
CRL
OCGN